Indivior Pharmaceuticals (INDV) Assets (2023 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Assets of $1.2 billion for Q1 2026, down 12.95% year-over-year from $1.4 billion in Q1 2025, and little changed quarter-over-quarter from $1.2 billion in Q4 2025.
Indivior Pharmaceuticals (INDV) Assets (2023 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Assets history runs 4 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- In Q1 2026, Assets fell 12.95% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (down 12.95% YoY), while the FY2025 annual figure was $1.2 billion, down 8.74% from the prior year.
- Assets for Q1 2026 stood at $1.2 billion, roughly flat from $1.2 billion in the prior quarter.
- The five-year high for Assets was $1.8 billion in Q4 2023, with the low at $1.2 billion in Q1 2026.
- The 4-year median for Assets is $1.4 billion (2025), against an average of $1.4 billion.
- The sharpest annual moves came in 2024 and 2025: Assets dropped 25.14% in 2024, then declined 8.74% in 2025.
- Indivior Pharmaceuticals' Assets stood at $1.8 billion in 2023, then fell by 25.14% to $1.3 billion in 2024, then fell by 8.74% to $1.2 billion in 2025, then fell by 0.33% to $1.2 billion in 2026.
- Business Quant data shows INDV's Assets at $1.2 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 6.18 Bn |
| 10 | Indivior Pharmaceuticals | 4.58 Bn | 4.36 Bn | 294.00 Mn | 1.23 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Bn |
| Mar 31, 2026 | 1.20 Bn |
| Dec 31, 2025 | 1.20 Bn |
| Sep 30, 2025 | 1.42 Bn |
| Jun 30, 2025 | 1.45 Bn |
| Mar 31, 2025 | 1.38 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Dec 31, 2023 | 1.76 Bn |